Literature DB >> 283423

Influence of hyperinsulinemia, hyperglycemia, and the route of glucose administration on splanchnic glucose exchange.

R A DeFronzo, E Ferrannini, R Hendler, J Wahren, P Felig.   

Abstract

The effects of hyperinsulinemia, hyperglycemia, and the route of glucose administration on total glucose utilization and on net splanchnic glucose exchange were studied in 20 normal volunteers with the hepatic venous catheter technique. Euglycemic hyperinsulinemia [induced by a priming plus continuous infusion of insulin resulting in plasma insulin levels of 400-1200 muunits (international)/ml and a variable glucose infusion] caused a 5- to 6-fold increase above basal in total glucose turnover. However, net splanchnic glucose uptake (0.5 +/- 0.2 mg/kg per min) accounted for only 4-5% of total glucose utilization. When hyperglycemia (223 +/- 1 mg/dl) was induced in addition to hyperinsulinemia by the intravenous infusion of glucose, splanchnic glucose uptake increased 100% to 1.0-1.1 mg/kg per min but was still responsible for only 10-14% of total glucose utilization. In other studies hyperglycemia (223 +/- 2 mg/dl) was maintained constant by a variable intravenous infusion of glucose for 4 hr and oral glucose (1.2 gm/kg) was administered at 1 hr. After the oral glucose, net splanchnic glucose uptake increased to values 6-fold higher than with intravenous glucose despite unchanged plasma glucose levels and plasma insulin concentrations well below those observed in the studies with euglycemic hyperinsulinemia. The results indicate that hyperinsulinemia or hyperglycemia induced by intravenous infusion of glucose or insulin causes minimal net uptake of glucose by the splanchnic bed despite marked stimulation of total glucose turnover. In contrast, administration of glucose by the oral route has a marked stimulatory effect on net splanchnic glucose uptake. These findings suggest that orally consumed glucose causes the release of a gastrointestinal factor that enhances insulin-mediated glucose uptake by the liver.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 283423      PMCID: PMC336287          DOI: 10.1073/pnas.75.10.5173

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  19 in total

1.  INHIBITION BY INSULIN OF HEPATIC GLUCOSE PRODUCTION IN THE NORMAL DOG.

Authors:  R STEELE; J S BISHOP; A DUNN; N ALTSZULER; I RATHBEB; R C DEBODO
Journal:  Am J Physiol       Date:  1965-02

2.  Glucose and fructose absorption in the unanesthetized dog.

Authors:  W C SHOEMAKER; H M YANOF; L N TURK; T H WILSON
Journal:  Gastroenterology       Date:  1963-05       Impact factor: 22.682

3.  Quantitative relations between the oral and intravenous glucose tolerance curves.

Authors:  R O SCOW; J CORNFIELD
Journal:  Am J Physiol       Date:  1954-12

4.  STUDIES OF THE ROLE OF THE LIVER IN HUMAN CARBOHYDRATE METABOLISM BY THE VENOUS CATHETER TECHNIC. I. NORMAL SUBJECTS UNDER FASTING CONDITIONS AND FOLLOWING THE INJECTION OF GLUCOSE.

Authors:  P K Bondy; D F James; B W Farrar
Journal:  J Clin Invest       Date:  1949-03       Impact factor: 14.808

5.  Influence of maturity-onset diabetes on splanchnic glucose balance after oral glucose ingestion.

Authors:  P Felig; J Wahren; R Hendler
Journal:  Diabetes       Date:  1978-02       Impact factor: 9.461

6.  Glucose intolerance in uremia. Quantification of pancreatic beta cell sensitivity to glucose and tissue sensitivity to insulin.

Authors:  R A DeFronzo; J D Tobin; J W Rowe; R Andres
Journal:  J Clin Invest       Date:  1978-08       Impact factor: 14.808

7.  Insulin binding to monocytes and insulin action in human obesity, starvation, and refeeding.

Authors:  R A DeFronzo; V Soman; R S Sherwin; R Hendler; P Felig
Journal:  J Clin Invest       Date:  1978-07       Impact factor: 14.808

8.  Integrated control of hepatic glucose metabolism.

Authors:  R N Bergman
Journal:  Fed Proc       Date:  1977-02

9.  Influence of endogenous insulin secretion on splanchnic glucose and amino acid metabolism in man.

Authors:  P Felig; J Wahren
Journal:  J Clin Invest       Date:  1971-08       Impact factor: 14.808

10.  Splanchnic and peripheral glucose and amino acid metabolism in diabetes mellitus.

Authors:  J Wahren; P Felig; E Cerasi; R Luft
Journal:  J Clin Invest       Date:  1972-07       Impact factor: 14.808

View more
  60 in total

1.  Intraportal glucose delivery enhances the effects of hepatic glucose load on net hepatic glucose uptake in vivo.

Authors:  S R Myers; D W Biggers; D W Neal; A D Cherrington
Journal:  J Clin Invest       Date:  1991-07       Impact factor: 14.808

2.  Intestinal handling of a glucose gavage by the rat.

Authors:  J A Fernández-López; J Casado; J M Argilés; M Alemany
Journal:  Mol Cell Biochem       Date:  1992-07-06       Impact factor: 3.396

Review 3.  Regulation of hepatic glucose uptake and storage in vivo.

Authors:  Mary Courtney Moore; Katie C Coate; Jason J Winnick; Zhibo An; Alan D Cherrington
Journal:  Adv Nutr       Date:  2012-05-01       Impact factor: 8.701

4.  Intraportal glucose delivery alters the relationship between net hepatic glucose uptake and the insulin concentration.

Authors:  S R Myers; O P McGuinness; D W Neal; A D Cherrington
Journal:  J Clin Invest       Date:  1991-03       Impact factor: 14.808

5.  Effect of insulin on the distribution and disposition of glucose in man.

Authors:  E Ferrannini; J D Smith; C Cobelli; G Toffolo; A Pilo; R A DeFronzo
Journal:  J Clin Invest       Date:  1985-07       Impact factor: 14.808

6.  Insulin effect in chronic alcoholics during alcohol withdrawal.

Authors:  N Adner; A Nygren
Journal:  Diabetologia       Date:  1982-03       Impact factor: 10.122

7.  Abnormal meal carbohydrate disposition in insulin-dependent diabetes. Relative contributions of endogenous glucose production and initial splanchnic uptake and effect of intensive insulin therapy.

Authors:  G Pehling; P Tessari; J E Gerich; M W Haymond; F J Service; R A Rizza
Journal:  J Clin Invest       Date:  1984-09       Impact factor: 14.808

8.  Superior Glycemic Control With a Glucose-Responsive Insulin Analog: Hepatic and Nonhepatic Impacts.

Authors:  Mary Courtney Moore; David E Kelley; Raul C Camacho; Peter Zafian; Tian Ye; Songnian Lin; Niels C Kaarsholm; Ravi Nargund; Terri M Kelly; Margaret Van Heek; Stephen F Previs; Christopher Moyes; Marta S Smith; Ben Farmer; Phil Williams; Alan D Cherrington
Journal:  Diabetes       Date:  2018-03-14       Impact factor: 9.461

9.  Differential effects of insulin on splanchnic and peripheral glucose disposal after an intravenous glucose load in man.

Authors:  L Saccà; M Cicala; B Trimarco; B Ungaro; C Vigorito
Journal:  J Clin Invest       Date:  1982-07       Impact factor: 14.808

10.  Insulin sensitivity and insulin binding to monocytes in maturity-onset diabetes.

Authors:  R DeFronzo; D Deibert; R Hendler; P Felig; V Soman
Journal:  J Clin Invest       Date:  1979-05       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.